Construct: ORF TRCN0000467202
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF001732.1_s317c1
- Derived from:
- ccsbBroadEn_10510
- DNA Barcode:
- CCCGAATCTTACTTCGGTGAATTA
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- CSGALNACT1 (55790)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000467202
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001130518.1 | 53.4% | 52.7% | (many diffs) |
| 2 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354475.1 | 53.4% | 52.7% | (many diffs) |
| 3 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354476.1 | 53.4% | 52.7% | (many diffs) |
| 4 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354477.1 | 53.4% | 52.7% | (many diffs) |
| 5 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354480.1 | 53.4% | 52.7% | (many diffs) |
| 6 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354481.1 | 53.4% | 52.7% | (many diffs) |
| 7 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354483.1 | 53.4% | 52.7% | (many diffs) |
| 8 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354484.1 | 53.4% | 52.7% | (many diffs) |
| 9 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354485.1 | 53.4% | 52.7% | (many diffs) |
| 10 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354487.1 | 53.4% | 52.7% | (many diffs) |
| 11 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354488.1 | 53.4% | 52.7% | (many diffs) |
| 12 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354489.1 | 53.4% | 52.7% | (many diffs) |
| 13 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354490.1 | 53.4% | 52.7% | (many diffs) |
| 14 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354491.1 | 53.4% | 52.7% | (many diffs) |
| 15 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354492.1 | 53.4% | 52.7% | (many diffs) |
| 16 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354494.1 | 53.4% | 52.7% | (many diffs) |
| 17 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354495.1 | 53.4% | 52.7% | (many diffs) |
| 18 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354496.1 | 53.4% | 52.7% | (many diffs) |
| 19 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354497.1 | 53.4% | 52.7% | (many diffs) |
| 20 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354498.1 | 53.4% | 52.7% | (many diffs) |
| 21 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_001354499.1 | 53.4% | 52.7% | (many diffs) |
| 22 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NM_018371.4 | 53.4% | 52.7% | (many diffs) |
| 23 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_006716360.3 | 53.4% | 52.7% | (many diffs) |
| 24 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_006716363.1 | 53.4% | 52.7% | (many diffs) |
| 25 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_006716364.3 | 53.4% | 52.7% | (many diffs) |
| 26 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_011544578.2 | 53.4% | 52.7% | (many diffs) |
| 27 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_011544579.2 | 53.4% | 52.7% | (many diffs) |
| 28 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_011544583.1 | 53.4% | 52.7% | (many diffs) |
| 29 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_011544584.1 | 53.4% | 52.7% | (many diffs) |
| 30 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_017013623.2 | 53.4% | 52.7% | (many diffs) |
| 31 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_017013624.2 | 53.4% | 52.7% | (many diffs) |
| 32 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_017013625.1 | 53.4% | 52.7% | (many diffs) |
| 33 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_017013627.1 | 53.4% | 52.7% | (many diffs) |
| 34 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_017013628.2 | 53.4% | 52.7% | (many diffs) |
| 35 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_017013629.1 | 53.4% | 52.7% | (many diffs) |
| 36 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_017013638.1 | 53.4% | 52.7% | (many diffs) |
| 37 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_024447190.1 | 53.4% | 52.7% | (many diffs) |
| 38 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_024447191.1 | 53.4% | 52.7% | (many diffs) |
| 39 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_024447192.1 | 53.4% | 52.7% | (many diffs) |
| 40 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_024447193.1 | 53.4% | 52.7% | (many diffs) |
| 41 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XM_024447194.1 | 53.4% | 52.7% | (many diffs) |
| 42 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NR_024040.2 | 22.3% | (many diffs) | |
| 43 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NR_148897.1 | 22.1% | (many diffs) | |
| 44 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NR_148899.1 | 22% | (many diffs) | |
| 45 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NR_148900.1 | 21.8% | (many diffs) | |
| 46 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NR_148898.1 | 21.6% | (many diffs) | |
| 47 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | XR_001745560.2 | 20% | (many diffs) | |
| 48 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NR_148901.1 | 19.8% | (many diffs) | |
| 49 | human | 55790 | CSGALNACT1 | chondroitin sulfate N-acety... | NR_148902.1 | 18.4% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 957
- ORF length:
- 891
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 ttggcatgat gatggttcgc cgggggctgc ttgcgtggat ttcccgggtg gtggttttgc 121 tggtgctcct ctgctgtgct atctctgtcc tgtacatgtt ggcctgcacc ccaaaaggtg 181 acgaggagca gctggcactg cccagggcca acagccccac ggggaaggag gggtaccagg 241 ccgtccttca ggagtgggag gagcagcacc gcaactacgt gagcagcctg aagcggcaga 301 tcgcacagct caaggaggag ctgcaggaga ggagtgagca gctcaggaat gggcagtacc 361 aagccagcga tgctgctggc ctgggtctgg acaggagccc cccagagaaa acccaggccg 421 acctcctggc cttcctgcac tcgcaggtgg acaaggcaga ggtgaatgct ggcgtcaagc 481 tggccacaga gtatgcagca gtgcctttcg atagctttac tctacagaag gtgtaccagc 541 tggagactgg ccttacccgc caccccgagg agaagcctgt gaggaaggac aagcgggatg 601 agttggtgga agcCATTGAA TCAGCCTTGG AGACCCTGAA CAATCCTGCA GAGAACAGCC 661 CCAATCACCG TCCTTACACG GCCTCTGATT TCATAGAAGG GATCTACCGA ACAGAAAGGG 721 ACAAAGGGAC ATTGTATGAG CTCACCTTCA AAGGGGACCA CAAACATGAA TTCAAACGGC 781 TCATCTTATT TCGACCATTC GGCCCCATCA TGAAAGTGGA AAATGAAAAG CTCAACATGG 841 CCAACACGCT TATCAATGTT ATCGTGCCTC TAGCAAAAAG GGTGGACAAG TTCCGGCAGT 901 TCATGCAGAA TTTCAGGCCT GCTGATGAAG TTTTTAGATG TGTGCCTTTA AGCCCTTGCC 961 CAACTTTCTT GTACAAAGTG GTTGATATCG GTAAGCCTAT CCCTAACCCT CTCCTCGGTC 1021 TCGATTCTAC GTAGTAATGA ACTAGTCCGT AACTTGAAAG TATTTCGATT TCTTGGCTTT 1081 ATATATCTTG TGGAAAGGAC GACCCGAATC TTACTTCGGT GAATTAACGC GTTAAGTCga 1141 caatcaacct ctggattaca aaatttgtga aagatt